1. Chen, Saipeng, Xiao, Longfei, Peng, Huahong, Wang, Zhen, Xie, Jianbing. 2021. Methylation gene KCNC1 is associated with overall survival in patients with seminoma. In Oncology reports, 45, . doi:10.3892/or.2021.8024. https://pubmed.ncbi.nlm.nih.gov/34105734/
2. Lian, Piaopiao, Cai, Xing, Wang, Cailin, Cao, Xuebing, Xu, Yan. 2023. Identification of metabolism-related subtypes and feature genes in Alzheimer's disease. In Journal of translational medicine, 21, 628. doi:10.1186/s12967-023-04324-y. https://pubmed.ncbi.nlm.nih.gov/37715200/
3. Spinelli, Sara, Remigante, Alessia, Liuni, Raffaella, Morabito, Rossana, Dossena, Silvia. 2024. Oxidative stress-related cellular aging causes dysfunction of the Kv3.1/KCNC1 channel reverted by melatonin. In Aging cell, 23, e14185. doi:10.1111/acel.14185. https://pubmed.ncbi.nlm.nih.gov/38725150/
4. Nascimento, Fábio A, Andrade, Danielle M. . Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations. In Epileptic disorders : international epilepsy journal with videotape, 18, 135-138. doi:. https://pubmed.ncbi.nlm.nih.gov/27629860/
5. Muona, Mikko, Berkovic, Samuel F, Dibbens, Leanne M, Palotie, Aarno, Lehesjoki, Anna-Elina. 2014. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy. In Nature genetics, 47, 39-46. doi:10.1038/ng.3144. https://pubmed.ncbi.nlm.nih.gov/25401298/